Risk of chronic kidney disease in type 2 diabetes determined by polymorphisms in NOS3, APOB, KCNJ11, TCF7L2 genes as compound effect of risk genotypes combination

Genetic susceptibility plays an important role in the risk of developing chronic complications in patients with type 2 diabetes mellitus (T2DM).
Aims.
In this study, we evaluated the possible association of the polymorphic variants that encode key renal damage mediators (endothelial dysfunction, lipid metabolism and insulin secretion/sensitivity) with the risk of chronic kidney disease (CKD) in patients with T2DM.
Materials and Methods.
We enrolled 435 patients with T2DM using case-control study design. In 253 patients, we used non-overlapping criteria to form groups with/without CKD (defined as GFR<60 ml/min/1.73 m²) according to the duration of T2DM (?5 years/>=10 years) (n=75 and 178, respectively) and analysed the following 4 polymorphic markers: I/D in ACE, ecNOS4a/4b in NOS3, I/D in APOB and e2/e3/e4 in APOE genes. We then divided 182 patients in groups with/without CKD (n=38 and 144, respectively) regardless of the duration of diabetes and studied pro12ala in PPARG2, rs5219 in KCNJ11, rs12255372 in TCF7L2 and rs13266634 in SLC30A8 genes.
² test, and data were expressed as odds ratios (ORs) with 95% confidence intervals (CIs). Values of p <0.05 indicated statistical significance.
Results.
Four genes were found to have a significant association with CKD occurrence. For the eNOS3 the allele 4a and 4a/4a genotype was associated with a twofold CKD risk (OR=2.2/9.88) and the allele 4b and 4b/4b polymorphism were protective regarding CKD development (OR=0.44/0.45). For APOB I/D, the genotype DD was associated with lower risk of CKD [OR for DD=0.2 (95% CI: 0.05?0.88)]. In the second group, genotype TT of TCF7L2 predisposed to CKD (OR=3.03, 95% CI: 1.07?8.58). For KCNJ11 group genotype AA predisposed to CKD (OR=2.25, 95% CI: 1.02?4.97) compared to the allele G (OR=0,57, 95% CI: 0.34?0.96).
Conclusions.
In conclusion, our findings indicate a significant role of functional genetic variants associated with genes of endothelial factors (NOS3), lipid metabolism (APOB), and insulin secretion factors (KCNJ11, TCF7L2) in modulating the risk of CKD and their significant involvement in the mechanism of kidney damage in patients with T2DM.

diabetes mellitus, genes, CKD, NOS3, APOB, TCF7L2, KCNJ11

1. Maslova OV, Suntsov YI, Shestakova MV, Kazakov IV, Vikulova OK, Sukhareva OY, et al. Prevalence of renal lesions in patients with type 1 and 2 diabetes mellitus in the Russian Federation. Diabetes mellitus 2009; (4):47-51. Available from: http://endojournals.ru/index.php/dia/article/view/5704 doi: 10.14341/2072-0351-5704

2. Shestakova MV, Dedov II. Diabetus mellitus and Chronic kidney disease. Moscow; 2009.

3. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International Supplements.2013;3(1):1–150. Available from: http://www.kdigo.org/clinical_practice_guidelines/pdf/CKD/KDIGO_2012_CKD_GL.pdf

4. Fogarty DG, Rich SS, Hanna L, Warram JH, Krolewski AS. Urinary albumin excretion in families with type 2 diabetes is heritable and genetically correlated to blood pressure. Kidney Int 2000;57(1):250-257. Available from: http://www.nature.com/doifinder/10.1046/j.1523-1755.2000.00833.x PubMed PMID: 10620206. doi: 10.1046/j.1523-1755.2000.00833.x

5. Seaquist ER, Goetz FC, Rich S, Barbosa J. Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy.. N Engl J Med 1989;320(18):1161-1165. Available from: http://www.nejm.org/doi/abs/10.1056/NEJM198905043201801 PubMed PMID: 2710189. doi: 10.1056/NEJM198905043201801

6. Zeng Z, Li L, Zhang Z, Li Y, Wei Z, Huang K, et al. A meta-analysis of three polymorphisms in the endothelial nitric oxide synthase gene (NOS3) and their effect on the risk of diabetic nephropathy. Hum Genet 2010;127(4):373-381. Available from: http://link.springer.com/10.1007/s00439-009-0783-x PubMed PMID: 20049477. doi: 10.1007/s00439-009-0783-x

7. Ma Z, Chen R, Ren H, Guo X, Chen JG, Chen L. Endothelial nitric oxide synthase (eNOS) 4b/a polymorphism and the risk of diabetic nephropathy in type 2 diabetes mellitus: A meta-analysis. Meta Gene 2014;2:50-62. Available from: http://linkinghub.elsevier.com/retrieve/pii/S2214540013000315 doi: 10.1016/j.mgene.2013.10.015

8. Pulkkinen A, Viitanen L, Kareinen A, Lehto S, Vauhkonen I, Laakso M. Intron 4 polymorphism of the endothelial nitric oxide synthase gene is associated with elevated blood pressure in type 2 diabetic patients with coronary heart disease. J Mol Med 2000;78(7):372-379. Available from: http://link.springer.com/10.1007/s001090000124 PubMed PMID: 11043380. doi: 10.1007/s001090000124

9. Ng DPK, Tai BC, Koh D, Tan KW, Chia KS. Angiotensin-I converting enzyme insertion/deletion polymorphism and its association with diabetic nephropathy: a meta-analysis of studies reported between 1994 and 2004 and comprising 14,727 subjects. Diabetologia 2005;48(5):1008-1016. Available from: http://link.springer.com/10.1007/s00125-005-1726-2 PubMed PMID: 15830182. doi: 10.1007/s00125-005-1726-2

10. Shestakova MV, Vikulova OK, Gorashko NM, Voronko OE, Babunova NB, Nosikov VV, et al. The relationship between genetic and haemodynamic factors in diabetic nephropathy (DN): Case–control study in type 1 diabetes mellitus (T1DM). Diabetes Res Clin Pract. 2006; 74(2):S41-50. doi: 10.1016/j.diabres.2006.06.013

11. Tolonen N, Forsblom C, Thorn L, Wadén J, Rosengård-Bärlund M, Saraheimo M, et al. Lipid abnormalities predict progression of renal disease in patients with type 1 diabetes. Diabetologia 2009;52(12):2522-2530. Available from: http://link.springer.com/10.1007/s00125-009-1541-2 PubMed PMID: 19816673. doi: 10.1007/s00125-009-1541-2

12. Hixson JE, McMahan CA, McGill HC, Strong JP. Apo B insertion/deletion polymorphisms are associated with atherosclerosis in young black but not young white males. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arteriosclerosis, Thrombosis, and Vascular Biology 1992;12(9):1023-1029. Available from: http://atvb.ahajournals.org/cgi/doi/10.1161/01.ATV.12.9.1023 PubMed PMID: 1525116. doi: 10.1161/01.ATV.12.9.1023

13. Vikulova OK. Kliniko-laboratornye i geneticheskie faktory razvitiya i progressirovaniya diabeticheskoy nefropatii u bol'nykh sakharnym diabetom 1 tipa [dissertation]. Moscow: 2003.

14. Araki S, Koya D, Makiishi T, Sugimoto T, Isono M, Kikkawa R, et al. APOE Polymorphism and the Progression of Diabetic Nephropathy in Japanese Subjects With Type 2 Diabetes: Results of a prospective observational follow-up study. Diabetes Care 2003 Авг;26(8):2416-2420. Available from: http://care.diabetesjournals.org/cgi/doi/10.2337/diacare.26.8.2416 PubMed PMID: 12882872. doi: 10.2337/diacare.26.8.2416

15. Yoshida H, Feig JE, Morrissey A, Ghiu IA, Artman M, Coetzee WA. KATP channels of primary human coronary artery endothelial cells consist of a heteromultimeric complex of Kir6.1, Kir6.2, and SUR2B subunits. Journal of Molecular and Cellular Cardiology 2004;37(4):857-869. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0022282804001634 PubMed PMID: 15380676. doi: 10.1016/j.yjmcc.2004.05.022

16. Jin T, Liu L. Minireview: The Wnt Signaling Pathway Effector TCF7L2 and Type 2 Diabetes Mellitus. Molecular Endocrinology 2008;22(11):2383-2392. Available from: http://press.endocrine.org/doi/abs/10.1210/me.2008-0135 PubMed PMID: 18599616. doi: 10.1210/me.2008-0135

17. Fujita H, Morii T, Fujishima H, Sato T, Shimizu T, Hosoba M, et al. The protective roles of GLP-1R signaling in diabetic nephropathy: possible mechanism and therapeutic potential. Kidney Int 2014;85(3):579-589. Available from: http://www.nature.com/doifinder/10.1038/ki.2013.427 PubMed PMID: 24152968. doi: 10.1038/ki.2013.427

18. Maeda S, Osawa N, Hayashi T, Tsukada S, Kobayashi M, Kikkawa R. Genetic variations associated with diabetic nephropathy and type II diabetes in a Japanese population. Kidney Int Suppl 2007;-(106):43-48. doi: 10.1038/sj.ki.5002385

19. Franceschini N, Shara NM, Wang H, Voruganti, Saroja V , Laston S, Haack K, et al. The association of genetic variants of type 2 diabetes with kidney function. Kidney Int 2012;82(2):220-225. Available from: http://www.nature.com/doifinder/10.1038/ki.2012.107 PubMed PMID: 22513821. doi: 10.1038/ki.2012.107

20. Hu C, Zhang R, Wang C, Wang J, Ma X, Lu J, et al. PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 are associated with type 2 diabetes in a Chinese population. PLoS One. 2009;4(10):e7643. doi: 10.1371/journal.pone.0007643